00768nas a2200277   4500000000100000000000100001008004100002100001400043700001600057700001600073700001400089700001700103700001300120700001200133700001000145700001800155700002200173700001200195700001200207700001600219700001600235700001600251245019400267250001500461020001400476       2022                            d1 aH. Danysh1 aC. Johannes1 aD. Beachler1 aJ. Layton1 aR. Ziemiecki1 aA. Arana1 aJ. Dinh1 aL. Li1 aB. Calingaert1 aM. Pladevall-Vila1 aP. Hunt1 aH. Chen1 aC. Karlsson1 aK. Johnsson1 aA. Gilsenan00aPost-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting  a2022/12/31  a0114-5916